Neutralizing antibodies are thought to be key to the development of an efficient vaccine against SARS-CoV-2. Researchers at the University of Montreal Hospital Research Centre (CRCHUM) indicate that ensuring their presence over long periods of time might be required.
We are not all equal during the lockdown. The easing of the lockdown won’t change anything. Beyond social, demographic and regional inequalities, immunosuppressed people are more affected than the average population. A CRCHUM research team is documenting the consequences of the pandemic on the healthy lifestyles and mental health of the immunosuppressed.
Did you know that, nationally, 20% of the adult population suffers from chronic pain? Lasting longer than three months, this pain may occur with no known cause or may be associated with headaches, arthritis or diseases such as cancer or diabetes.
In order to offer support to the hospital sector during the fight against COVID-19, researchers from École de technologie supérieure (ÉTS), the Centre hospitalier de l’Université de Montréal (CHUM) Research Centre and the CIUSSS du Nord-de-l’île-de-Montréal (CIUSSS NIM) have joined forces with the clinical teams at CHUM and CIUSSS NIM to provide 3D printing services f
Under a joint initiative by the Fonds de recherche du Québec and Génome Québec, a task force combining research teams from across the province, including those of the University of Montreal Hospital Research Centre (CRCHUM) and the Université de Montréal, will set up the first Quebec Biobank to advance research efforts studying COVID-19, a disease caused by a new type of virus in the coronaviru
A New Multidisciplinary Approach for Detecting and Treating Amyloidosis
What do heart failure, bruising around the eyes and carpal tunnel syndrome have in common? They are a few of the many signs and symptoms seen in patients with amyloidosis, a rare but often fatal disease for which the CHUM now offers a new treatment approach.
Montreal, November 22, 2019 ─ A hospital corridor has been transformed into an exercise track for patients in the CHUM’s stroke unit, thanks to the new LOCOMOTIVE circuit that provides information and exercises to get patients moving, keep their minds active and encourag
CHUM announced today the creation of the Centre de référence des anomalies neurovasculaires rares du CHUM (referral centre for rare neurovascular abnormalities), an initiative unlike any other in Canada for patients with often poorly known diseases of the nervous system.
Montréal, November 14, 2018 — Today, CHUM and Université de Montréal announce the creation of the first school of artificial intelligence applied to the health sector from a Francophone environment, the École de l'intelligence artificielle en santé du CHUM (EIAS).